FDA Clearance Tracker · K121446
BACT/ALERT PF PLUS CULTURE BOTTLE
Last checked: Nov 20, 2026Latest source record: Jan 25, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Jan 25, 2013
Substantially Equivalent
Time to decision
255 days
Received May 15, 2012. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K121446
- Device name
- BACT/ALERT PF PLUS CULTURE BOTTLE
- Applicant
- bioMerieux, Inc.
- Applicant location
- Durham, NC
- Received
- May 15, 2012
- Decided
- Jan 25, 2013
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Blood Culturing (MDB)
- Device class
- Class I
- Regulation
- 21 CFR 866.2560
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MDB. The earliest in FDA's data is K810613, decided Apr 3, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K121446
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for bioMerieux, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262807 · Decided Nov 4, 2026 · 89 days after receipt
Device type: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (LON) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.